Massachusetts General Hospital
Clinical trials sponsored by Massachusetts General Hospital, explained in plain language.
-
Could a new drug help heart failure patients breathe easier and think sharper?
Disease control Not yet recruitingThis study tests whether an investigational drug (activin ligand-trap) combined with exercise training can improve exercise capacity and thinking skills in people with a type of heart failure called HFpEF. About 48 adults aged 40 and older with obesity will receive either the dru…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 03:01 UTC
-
Could a cancer drug make dual transplants safer?
Disease control Not yet recruitingThis early-phase study tests whether adding the drug venetoclax to a standard transplant procedure is safe for people with both kidney failure and a blood cancer. Only 3 adults aged 18-70 will take part. The goal is to see if the drug helps the body accept the new kidney and stem…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 02:58 UTC
-
Cash for clean blood: new study tests money incentives to fight Alcohol-Liver disease
Disease control Not yet recruitingThis study tests whether offering financial rewards based on a blood test can help people with alcohol-related liver disease stop or reduce drinking. The blood test detects alcohol use over the past month. Participants are randomly assigned to receive either escalating rewards fo…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 02:55 UTC
-
New hope for Hard-to-Treat lung cancer: ivonescimab combo shows promise
Disease control Not yet recruitingThis study tests a new drug, ivonescimab, alone or with chemotherapy, in 46 people with advanced non-small cell lung cancer that has specific gene changes and has not responded to prior treatments. The goal is to see if the drug can shrink tumors or slow cancer growth. Participan…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 02:54 UTC
-
New hope for myeloma patients: ELDORADO trial tests powerful drug combo without transplant
Disease control Not yet recruitingThis study tests whether a new drug combination (elranatamab plus standard medications) works better than the current standard (daratumumab plus standard medications) for people newly diagnosed with multiple myeloma who are not eligible for or choose not to have a stem cell trans…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 02:52 UTC
-
Could a cream reduce moles before surgery?
Disease control Not yet recruitingThis study tests a cream called SADBE on large congenital moles before they are surgically removed. The goal is to see if the cream can safely reduce the number of pigment-producing cells in the mole. About 30 adults with these moles will apply the cream for a few weeks before th…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 02:47 UTC
-
New drug combo aims to tackle Hard-to-Treat leukemia
Disease control Not yet recruitingThis early-stage study tests two experimental drugs, ziftomenib and mezigdomide, given together to adolescents and adults with a specific type of acute myeloid leukemia (AML) that has come back or not responded to treatment. The main goal is to find a safe dose and check for side…
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 02:47 UTC
-
Peer power: new program aims to keep young drug users in treatment and HIV-Free
Disease control Not yet recruitingThis pilot study will test whether a program called Yuva Sath, led by trained peer counselors, can help young people (ages 18-29) who inject drugs in India stay engaged in addiction treatment and use HIV prevention services. Sixty participants will receive one-on-one sessions and…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 02:46 UTC
-
Experimental drug targets obesity in rare genetic condition
Disease control Not yet recruitingThis study tests whether setmelanotide can help a single patient with pseudohypoparathyroidism type 1a (a rare genetic disorder) lose weight. The patient will take the drug for 6 months, and researchers will measure weight loss, body fat, and blood sugar levels. The goal is to se…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 02:45 UTC
-
Could a common blood pressure pill boost chemo for resistant ovarian cancer?
Disease control Not yet recruitingThis study tests whether adding losartan (a blood pressure medicine) to weekly paclitaxel chemotherapy can shrink tumors in people with ovarian cancer that no longer responds to platinum-based drugs. About 27 adults with advanced ovarian, fallopian tube, or primary peritoneal can…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New combo therapy aims to shrink head and neck tumors before main treatment
Disease control Not yet recruitingThis study tests a combination of the immunotherapy drug toripalimab with two chemotherapy drugs (cisplatin and docetaxel) as an initial treatment for people with advanced head and neck cancer that has a specific marker (CPS-positive). The goal is to see if this approach is safe …
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 20, 2026 12:08 UTC
-
Major trial to find best drug for rare autoimmune disease
Disease control Not yet recruitingThis study compares five FDA-approved drugs to see which one works best to prevent relapses in people with NMOSD, a rare autoimmune disease that can cause blindness and paralysis. About 540 adults who test positive for a specific antibody will be randomly assigned to receive ritu…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Diabetes drug shows promise for gout in new trial
Disease control Not yet recruitingThis study tests whether empagliflozin, a drug used for diabetes, can lower uric acid levels and reduce inflammation in people with gout. Sixty adults with gout and high urate levels will receive either empagliflozin or a placebo for 12 weeks. The goal is to see if this drug can …
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Laser zaps fat? new study tests Metabolism-Boosting light therapy
Disease control Not yet recruitingThis early study tests whether a special laser treatment applied to a large area of skin can improve metabolism in adults who are overweight. Researchers will measure changes in body fat, weight, and waist size in 15 participants. The goal is to see if this non-invasive approach …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Peer coaches take on tobacco in opioid recovery: a new hope for quitting smoking
Disease control Not yet recruitingThis study tests whether peer recovery coaches—people who have themselves recovered from opioid use—can help others quit smoking. About 60 adults on medication for opioid use disorder who smoke daily will receive either standard smoking-cessation support or coaching from a peer c…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New imaging technique could spot liver scarring earlier in PSC patients
Diagnosis Not yet recruitingThis study will test whether a special PET/MRI scan can better detect and measure scarring (fibrosis) in the bile ducts of people with primary sclerosing cholangitis (PSC). Ten adults with PSC will receive two different radioactive tracers during the scan, and results will be com…
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated May 26, 2026 02:57 UTC
-
New PET scan may spot hidden kidney cancer after treatment
Diagnosis Not yet recruitingThis study tests whether a special PET scan using 89Zr-girentuximab can detect kidney cancer that remains or comes back after initial treatment. Ten adults with clear cell renal cell carcinoma will receive the scan before and after standard cryoablation. The goal is to see if the…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated May 26, 2026 02:51 UTC
-
Sticky patch could spot breast lesions in minutes
Diagnosis Not yet recruitingThis study tests a wearable ultrasound patch that sticks to the breast and is held in place with a sports bra. The goal is to see if it can find breast lesions as accurately as a standard handheld ultrasound. About 50 women will try the patch during a short imaging session. Resea…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated May 22, 2026 14:03 UTC
-
New study explores Dye-Free CT scans for faster, safer clot detection
Diagnosis Not yet recruitingThis study tests whether a chest CT scan without contrast dye can accurately detect pulmonary emboli (blood clots in the lungs). About 750 adults with suspected clots will undergo two extra low-dose CT scans and a simple breathing test. If successful, this approach could offer a …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated May 20, 2026 11:57 UTC
-
Can a weekly call save lives? new trial aims to stop suicide after ER discharge
Prevention Not yet recruitingThis study tests whether extra support from a community crisis group (Samaritans of Boston) can help people who recently left the ER for suicidal thoughts. About 300 participants will either get weekly calls or texts plus standard care, or standard care alone. The goal is to see …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated May 26, 2026 02:55 UTC
-
Smart sleeve aims to stop breast cancer arm swelling before it starts
Prevention Not yet recruitingThis study tests whether a compression sleeve with a built-in sensor can stop mild arm swelling from turning into lymphedema after breast cancer surgery. About 40 women who have early signs of swelling will wear the sleeve and be monitored. The goal is to see if the sleeve helps …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated May 26, 2026 02:53 UTC
-
Choice and convenience: can Same-Day injections keep HIV at bay?
Prevention Not yet recruitingThis study tests whether giving people a choice of where to get their follow-up injections (home, community, or clinic) helps them stick with a new long-acting HIV prevention drug called lenacapavir. About 400 HIV-negative adults in Massachusetts will start the injection on the s…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated May 20, 2026 11:54 UTC
-
New support program aims to ease anxiety in Triple-Negative breast cancer survivors
Symptom relief Not yet recruitingThis study tests a nurse-led coping and support program called RESTORE for people who have finished treatment for triple-negative breast cancer. The goal is to see if the program is practical and helpful for reducing anxiety, fear of cancer returning, and improving quality of lif…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 03:02 UTC
-
Home health aide training aims to ease dementia symptoms
Symptom relief Not yet recruitingThis study tests whether giving home health aides extra training in dementia care can help reduce troubling behaviors in older adults with memory loss or dementia and improve quality of life for both patients and their care partners. About 120 patient-care partner pairs will take…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 03:00 UTC
-
Can a simple app help kidney patients feel better? new study aims to find out.
Symptom relief Not yet recruitingThis study tests whether having people with advanced chronic kidney disease (stages 4 and 5) regularly report their symptoms through an app—and sharing that info with their kidney doctor—can improve their quality of life. About 70 adults will either use the app for 12 months or r…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:59 UTC
-
Brain zaps tailored to you: new hope for PTSD?
Symptom relief Not yet recruitingThis study tests a personalized form of brain stimulation (PrTMS) for post-traumatic stress disorder (PTSD) in 100 military veterans. Unlike standard treatments, it uses a simple brainwave test (EEG) to customize therapy for each person. Participants will receive either active or…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:58 UTC
-
Could a common anxiety drug help autistic youth?
Symptom relief Not yet recruitingThis study tests whether buspirone, a medication used for anxiety, can safely reduce anxiety symptoms in autistic youth aged 7 to 17. Researchers will measure changes in anxiety severity over 16 weeks. The goal is to see if this drug is a good treatment option for this group.
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:54 UTC
-
Can a smartphone app help prevent suicide after psychiatric hospitalization?
Symptom relief Not yet recruitingThis study tests whether a combination of smartphone messages and brief therapy sessions can help adults who have been hospitalized for suicidal thoughts or attempts. About 360 participants will use a smartphone app to track their feelings and may receive automated coping reminde…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:52 UTC
-
Can eating only during certain hours help bipolar depression and weight?
Symptom relief Not yet recruitingThis study looks at whether eating only during an 8-hour window each day can help people with bipolar disorder who are overweight and depressed. Forty adults will either follow this eating schedule or stay on a waiting list for 8 weeks. Researchers will check weight, mood, and ot…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:52 UTC
-
Brain zaps and pills: new combo aims to kick nicotine for good
Symptom relief Not yet recruitingThis study tests whether adding a type of brain stimulation (accelerated TMS) to a standard quit-smoking drug (varenicline) helps adults stop using nicotine products like vapes or cigarettes. About 30 adults who want to quit will receive either real or fake TMS while taking varen…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:51 UTC
-
New breathing program aims to ease lung cancer patients' worst symptom
Symptom relief Not yet recruitingThis study tests a short program called BREEZE+ that helps people with advanced lung cancer manage breathlessness. It includes three sessions with a nurse and a smartphone app that teaches coping skills. The goal is to see if it reduces how much shortness of breath bothers patien…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:47 UTC
-
Creatine: a new shield for the aging brain during surgery?
Symptom relief Not yet recruitingThis study tests whether taking creatine, a supplement often used for muscle strength, can help protect the brain in older adults having surgery. Surgery can sometimes cause confusion or memory problems, especially in older people. Researchers will give creatine to 80 adults sche…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:46 UTC
-
Can a Mind-Body video program ease chronic hip pain? new study aims to find out
Symptom relief Not yet recruitingThis study tests two mind-body pain management programs delivered via live video for adults with chronic (3+ months) hip pain not caused by arthritis. Researchers want to see if the programs are satisfying, believable, and practical for a future larger trial. About 50 participant…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:46 UTC
-
Can a common supplement calm emotional outbursts in kids?
Symptom relief Not yet recruitingThis study tests whether N-Acetylcysteine (NAC), a supplement, can help children ages 6-12 who struggle with emotional dysregulation (intense mood swings or outbursts). About 80 children with emotional dysregulation will receive either NAC or a placebo for 8 weeks, while 40 typic…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:45 UTC
-
New pain relief approach for IR procedures under study
Symptom relief Not yet recruitingThis study tests whether a long-acting local anesthetic (liposomal bupivacaine) can reduce pain during and after interventional radiology procedures. Ten adult patients will receive the drug as part of standard care, and report their pain levels at several time points. The goal i…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Can a phone app curb suicidal urges? new study aims to find out.
Symptom relief Not yet recruitingThis study tests a smartphone app called TEC-S designed to reduce suicidal thoughts and behaviors. About 60 adults who have frequent suicidal thoughts will use the app for two weeks. Researchers will check if the app lowers their desire to die and improves safety.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
New anesthesia approach aims to cut opioid use after spine surgery
Symptom relief Not yet recruitingThis study tests a type of anesthesia that uses fewer opioids during spine surgery in people aged 65 and older. The goal is to see if it lowers pain and the need for strong painkillers after surgery. Half the participants will get this opioid-sparing anesthesia, and the other hal…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
New support program aims to ease emotional toll of ALS for patients and families
Symptom relief Not yet recruitingThis study tests a new program called Resilient Together-ALS for people recently diagnosed with ALS and their caregivers. The program uses mind-body techniques to help manage emotional distress and build coping skills. About 20 patient-caregiver pairs will participate to see if t…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
New tool helps teens map their social circles to beat alcohol addiction
Symptom relief Not yet recruitingThis study aims to help teens (ages 12-19) with alcohol use disorder by using a visual tool called SIM-AiR. The tool helps them understand how their social groups and identities affect their recovery. Researchers will ask 60 participants and their clinicians about how useful and …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 20, 2026 11:56 UTC
-
Can a One-Day combo treatment tighten aging arm skin better?
Symptom relief Not yet recruitingThis study tests whether getting two cosmetic treatments (Sculptra and Sofwave) on the same day works better than having them one month apart. It involves 13 adults aged 40 and older with loose skin on the upper arms. The goal is to see which approach improves skin tightness more…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC
-
Teens' worry hack: brain training meets mindfulness
Symptom relief Not yet recruitingThis study tests whether combining mindfulness practice with real-time brain feedback (neurofeedback) can reduce repetitive negative thinking in 90 teens aged 14-21 who are at risk for serious mental illness. Participants will practice mindfulness with either active or sham neuro…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC
-
Can a simple light stop the itch? new study aims to find out
Symptom relief Not yet recruitingThis study tests a non-invasive light device that uses near-infrared LED light to relieve itch. The device does not break the skin or produce heat. Researchers will enroll 20 adults with acute or chronic itch to see if the light is safe and can reduce itch intensity. Participants…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC
-
New program aims to ease NICU Parents' anxiety and strengthen relationships
Symptom relief Not yet recruitingThis study tests a program called 'Resilient Families' (R-FAM) designed to reduce emotional distress and improve relationships for parents of babies in the Neonatal Intensive Care Unit (NICU). About 50 parents will be randomly assigned to either the R-FAM program or receive stand…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 19, 2026 12:01 UTC
-
New program aims to ease emotional burden on families of coma patients
Symptom relief Not yet recruitingThis study tests a program called COMA-F designed to reduce emotional distress in caregivers of patients with severe acute brain injury. Researchers will compare it to a health education program in 150 caregivers. The goal is to see if the program improves anxiety, depression, an…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 18, 2026 12:09 UTC
-
AI texts aim to boost exercise in diabetes patients
Symptom relief Not yet recruitingThis study tests an 8-week program that sends encouraging messages to help adults with type 2 diabetes become more active and feel better. About 20 participants will use their smartphones to receive these messages. The goal is to see if the program is easy to use and helpful.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 18, 2026 12:09 UTC
-
New study tests resilience training for lymphoma survivors
Symptom relief Not yet recruitingThis study tests whether a mind-body resilience group program can help lymphoma survivors better cope with challenges after finishing treatment. About 254 adults who completed lymphoma treatment within the past two years will participate. The program focuses on relaxation, recogn…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 18, 2026 12:00 UTC
-
New study aims to help lymphoma survivors thrive after cancer treatment
Symptom relief Not yet recruitingThis study tests whether a resilience-building program can improve quality of life for lymphoma survivors who finished treatment within the last two years. About 254 adults will take part, comparing the resilience program to a health education program. The goal is to see if learn…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC
-
New natural gel for bacterial vaginosis passes first safety check
Symptom relief Not yet recruitingThis early-stage study tests whether LCFA-01, a natural gel containing oleic acid, is safe and comfortable when placed in the vagina. Thirty healthy women aged 18-40 will use the gel and be monitored for side effects, discomfort, and how much of the product enters the bloodstream…
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 12, 2026 13:42 UTC
-
Ear-ZAP! new TENS study targets fibromyalgia pain
Symptom relief Not yet recruitingThis study tests if a safe, non-invasive electrical stimulation device called TENS can reduce pain in people with fibromyalgia. Researchers will enroll 60 adults who will use the device twice a day for 4 weeks. The goal is to see if this simple treatment can improve daily life an…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 06, 2026 16:01 UTC
-
New colonoscopy camera aims to give doctors a better view
Knowledge-focused Not yet recruitingThis study is testing a new device that takes detailed pictures of the lower gut during a standard colonoscopy. The device, called a CC-OCT probe, is inserted through the colonoscope to capture real-time images. The goal is to see if this tool works well for imaging. About 250 ad…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:02 UTC
-
New study tests whether linking patients to recovery centers boosts opioid treatment success
Knowledge-focused Not yet recruitingThis study is testing a new program that helps people receiving medication for opioid use disorder connect with recovery community centers. The goal is to see if this program is practical, acceptable, and helpful for improving recovery. About 145 adults in Massachusetts who are o…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:01 UTC
-
Could heart disease start in the brain? new study uses full-body scans to find out.
Knowledge-focused Not yet recruitingThis study will use advanced PET scans to measure blood flow and energy use in the brain and body at the same time. Researchers want to see how these responses differ between healthy adults and people with heart disease, especially during mental or physical stress. The goal is to…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:00 UTC
-
Traffic light labels could steer food pantries toward healthier choices
Knowledge-focused Not yet recruitingThis study looks at whether using simple traffic light labels (green, yellow, red) on a food bank's online ordering system can encourage food pantries to pick healthier items. About 364 food agencies will take part, with some getting extra nudges to use the labels. The goal is to…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:57 UTC
-
Blood test may predict rectal cancer outcomes without extra treatment
Knowledge-focused Not yet recruitingThis study is for people with a certain type of rectal cancer that hasn't spread. Researchers want to see if a simple blood test that looks for tumor DNA can help track the cancer and find if it comes back earlier than usual scans. About 60 participants will give blood and tissue…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:55 UTC
-
New study aims to tackle depression and hunger to boost HIV treatment success
Knowledge-focused Not yet recruitingThis study in South Africa, where HIV is most common, looks at how problems like depression, trauma, and not having enough food can make HIV worse. Researchers are developing a special therapy (CBT-SA) to help people with HIV handle these issues and stick to their medication. The…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:55 UTC
-
New study aims to boost cervical cancer Follow-Up with personalized reminders
Knowledge-focused Not yet recruitingThis study tests whether personalized reminders help people get timely follow-up care after cervical cancer screening. About 7,500 participants from primary care clinics will be randomly assigned to standard care, visit-based reminders, or reminders plus outreach. The goal is to …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:55 UTC
-
Could earlier screening catch postpartum depression sooner?
Knowledge-focused Not yet recruitingThis study compares the usual timing of postpartum depression screening (at 6-8 weeks after birth) with an earlier screening at 2-3 weeks. Researchers will randomly assign 428 new mothers to either early or routine screening using a short online questionnaire. The goal is to see …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:54 UTC
-
New screening study aims to Fast-Track ALS patients to targeted trials
Knowledge-focused Not yet recruitingThis observational study screens 500 people with early-stage ALS (within 24 months of weakness onset) to see if they are eligible for specific early-phase ALS trials. Participants undergo clinical tests, lab work, and biomarker analysis. The study also builds a bank of blood samp…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:54 UTC
-
Brain injury recovery prediction study launches
Knowledge-focused Not yet recruitingThis study aims to better predict how people recover from severe brain injuries that leave them unconscious. Researchers will collect brain scans, EEG readings, and other medical information from 50 patients in the hospital. They will then check on patients 6 months later to see …
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC
-
Glow-in-the-Dark dye could spot hidden artery danger
Knowledge-focused Not yet recruitingThis study tests whether a special dye, called LUMISIGHT, can make inflammation in artery plaques visible after they are removed during surgery. Inflammation is a key driver of heart attacks and peripheral artery disease, but doctors currently lack a way to see it clearly. The st…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:46 UTC
-
Heart attack recovery: could a nudge get more patients to rehab?
Knowledge-focused Not yet recruitingThis study tests whether a combination of motivational phone calls for patients and informational alerts for doctors can increase attendance at cardiac rehabilitation after a type 2 heart attack. Researchers will compare this approach to usual care in 60 adults. The goal is to se…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Can a weekly check-in call prevent suicide after an ER visit?
Knowledge-focused Not yet recruitingThis study tests whether a community organization can provide weekly calls or texts to people who recently visited the emergency room for suicidal thoughts. The goal is to see if this kind of support is practical and well-received. Twenty participants will receive outreach for 12…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
New study tests best breathing support for severely obese patients after surgery
Knowledge-focused Not yet recruitingThis study looks at how different settings on a breathing machine (CPAP) affect heart and lung function in 60 severely obese adults after surgery. Participants will try two CPAP settings for 20 minutes each in the recovery room. The goal is to find which setting works better and …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
New training tool aims to sharpen radiation plan skills
Knowledge-focused Not yet recruitingThis study will create and test a new learning tool to help radiation oncology residents better review and improve radiation treatment plans. Twenty residents in their second to fourth year of training will use the tool and then take a test to see if their skills improved. The go…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC
-
Hot flash drug may unlock heart health secrets
Knowledge-focused Not yet recruitingThis study looks at whether a drug called elinzanetant, which targets hot flashes, can also improve blood vessel health in women aged 40-65 with moderate to severe hot flashes and heart disease risk factors. Researchers will measure blood vessel function and inflammatory markers.…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC
-
Estrogen replacement may shield hearts of women with premature ovarian failure
Knowledge-focused Not yet recruitingThis study looks at whether 6 months of estrogen replacement therapy can improve heart health in women with primary ovarian insufficiency (POI), a condition that causes early menopause. Researchers will measure blood vessel function and metabolic markers in 45 women aged 30-40 be…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC
-
Can an AI chatbot curb binge drinking in young adults?
Knowledge-focused Not yet recruitingThis study will test if a smart chatbot can help young adults aged 18-29 who drink heavily to reduce their alcohol use. The chatbot will have personalized conversations to encourage healthier drinking habits. The main goal is to see if young people find the chatbot easy and helpf…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC
-
New eye scanner aims to see retina like never before
Knowledge-focused Not yet recruitingThis study tests a new type of eye scanner (PS-OCT) to see if it can take clearer pictures of the retina's nerve fibers. About 20 healthy adults aged 18-85 will have their eyes imaged. The goal is to measure how well the device works, not to treat any disease.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:04 UTC
-
Can unconscious bias training help pharmacists better serve HIV prevention?
Knowledge-focused Not yet recruitingThis study aims to reduce racial bias among pharmacy interns who may prescribe HIV prevention medication (PrEP). Researchers will adapt a bias-reduction program and test if it is acceptable and feasible for pharmacy interns. The goal is to improve care for people of color at risk…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC
-
Rapid STI test aims to cut treatment wait times
Knowledge-focused Not yet recruitingThis study compares a rapid point-of-care test for gonorrhea and chlamydia to standard lab testing in 400 asymptomatic adults at an urban sexual health clinic. The goal is to see if faster results reduce the time to starting antibiotics and increase the number of people treated w…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 11:58 UTC